Cargando…
High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients
We evaluated the acute and late toxicity after high-dose intensity-modulated radiotherapy (IMRT) with fiducial marker-based position verification for prostate cancer. Between 2001 and 2004, 331 patients with prostate cancer received 76 Gy in 35 fractions using IMRT combined with fiducial marker-base...
Autores principales: | Lips, Irene M, Dehnad, Homan, van Gils, Carla H, Boeken Kruger, Arto E, van der Heide, Uulke A, van Vulpen, Marco |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430572/ https://www.ncbi.nlm.nih.gov/pubmed/18495016 http://dx.doi.org/10.1186/1748-717X-3-15 |
Ejemplares similares
-
EUS-guided fiducial marker placement for radiotherapy in rectal cancer: feasibility of two placement strategies and four fiducial types
por: Rigter, Lisanne S., et al.
Publicado: (2019) -
Single blind randomized Phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial
por: Lips, Irene M, et al.
Publicado: (2011) -
Intra- and inter-radiation therapist reproducibility of daily isocenter verification using prostatic fiducial markers
por: Ullman, Karen L, et al.
Publicado: (2006) -
Quantitative Magnetic Resonance Imaging for Biological Image-Guided Adaptive Radiotherapy
por: van Houdt, Petra J., et al.
Publicado: (2021) -
Technology‐driven research for radiotherapy innovation
por: Fiorino, Claudio, et al.
Publicado: (2020)